Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sherbrooke Capital is a U.S.-based private equity and growth capital investment firm focused on the health and wellness sector rather than a drug-development biotech company. Founded in 1999 and based in the Boston-area suburbs of Massachusetts, the firm invests in emerging companies whose products and services support healthy, active, and sustainable living. Its investment focus has spanned nutrition, food and beverage, medical devices, diagnostics, personal care, animal health, and related consumer health categories. Sherbrooke appears to operate as a private investment manager led by founder John Giannuzzi, with a small team and a portfolio that has included companies such as TransMedics, Petplan/Fetch, and other health- and wellness-oriented businesses. Because it is an investment firm, it does not appear to maintain an internal therapeutic pipeline, clinical-stage programs, or proprietary drug assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sherbrooke Capital.